Lombard Odier Asset Management Switzerland SA Purchases Shares of 101,000 The Clorox Company $CLX

Posted by Brian Himes on Jun 17th, 2026

Lombard Odier Asset Management Switzerland SA purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 101,000 shares of the company’s stock, valued at approximately $10,184,000. Lombard Odier Asset Management Switzerland SA owned about 0.08% of Clorox at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Vermillion & White Wealth Management Group LLC bought a new stake in shares of Clorox in the 3rd quarter valued at $25,000. Darwin Wealth Management LLC bought a new stake in shares of Clorox in the 2nd quarter valued at $29,000. Ameriflex Group Inc. boosted its stake in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the last quarter. Vision Financial Markets LLC boosted its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the last quarter. Finally, MUFG Securities EMEA plc bought a new stake in shares of Clorox in the 2nd quarter valued at $44,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $97.52 on Wednesday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock has a 50-day moving average of $96.26 and a 200-day moving average of $105.05. The company has a market cap of $11.79 billion, a PE ratio of 15.83, a P/E/G ratio of 0.50 and a beta of 0.56. The Clorox Company has a one year low of $84.70 and a one year high of $132.03.

Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period last year, the business posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.63% of the company’s stock.

Analyst Ratings Changes

CLX has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $91.00 price objective on shares of Clorox in a research note on Friday, May 1st. BNP Paribas Exane cut their target price on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. Citigroup cut their target price on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. The Goldman Sachs Group restated a “sell” rating and set a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. Finally, Evercore restated an “underperform” rating and set a $110.00 target price on shares of Clorox in a research report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $103.40.

Read Our Latest Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.